US Stock MarketDetailed Quotes

AVXL Anavex Life Sciences

Watchlist
  • 9.210
  • -0.940-9.26%
Close Jan 17 16:00 ET
  • 9.400
  • +0.190+2.06%
Pre 08:01 ET
781.15MMarket Cap-17.71P/E (TTM)

Anavex Life Sciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-10.89%-30.81M
-13.83%-6.66M
32.31%-5.18M
-37.31%-11.66M
-26.30%-7.32M
-14.63%-27.79M
-44.63%-5.85M
-8.50%-7.65M
11.94%-8.49M
-65.50%-5.79M
Net income from continuing operations
9.48%-43M
-14.53%-11.62M
-8.28%-12.21M
19.54%-10.55M
33.53%-8.62M
0.99%-47.51M
29.00%-10.15M
8.79%-11.28M
-25.57%-13.11M
-19.20%-12.97M
Other non cash items
----
----
----
----
----
--845K
--0
--0
----
----
Change In working capital
9.86%2.75M
160.36%2.89M
2,027.20%4.61M
-1,809.64%-3.76M
-153.63%-982K
-53.27%2.51M
-73.60%1.11M
-118.03%-239K
94.59%-197K
-47.27%1.83M
-Change in receivables
-46.28%260K
-34.25%-729K
-19.71%2.07M
63.30%-236K
6.87%-840K
-91.86%484K
-116.13%-543K
2,931.29%2.57M
41.38%-643K
-123.96%-902K
-Change in prepaid assets
7.02%-278K
-26.44%128K
84.52%286K
-80.12%-589K
65.78%-103K
-30,000.00%-299K
61.99%174K
5,766.77%155K
-276.97%-327K
-1,249.11%-301K
-Change in payables and accrued expense
54.03%2.85M
141.11%3.57M
176.03%2.26M
-479.95%-2.94M
-101.52%-39K
416.27%1.85M
102.65%1.48M
-309.84%-2.97M
131.45%773K
1,049.48%2.56M
-Change in other working capital
-115.86%-75K
----
----
----
----
--473K
--0
--0
--0
--473K
Cash from discontinued investing activities
Operating cash flow
-10.89%-30.81M
-13.83%-6.66M
32.31%-5.18M
-37.31%-11.66M
-26.30%-7.32M
-14.63%-27.79M
-44.63%-5.85M
-8.50%-7.65M
11.94%-8.49M
-65.50%-5.79M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-59.61%11.98M
-95.67%89K
-49.46%4.55M
-60.31%7.28M
-77.13%59K
39.29%29.65M
83,341.56%2.06M
30.28%9M
54.90%18.33M
-89.84%258K
Net common stock issuance
-59.52%11.28M
--0
-51.89%4.11M
----
----
32.83%27.88M
41,554.98%1.19M
29.65%8.53M
----
----
Proceeds from stock option exercised by employees
-61.09%691K
-89.75%89K
-5.33%444K
-45.30%99K
-77.13%59K
75.84%1.78M
456,942.11%868K
-8.62%469K
46.65%181K
-30.92%258K
Cash from discontinued financing activities
Financing cash flow
-59.61%11.98M
-95.67%89K
-49.46%4.55M
-60.31%7.28M
-77.13%59K
39.29%29.65M
83,341.56%2.06M
30.28%9M
54.90%18.33M
-89.84%258K
Net cash flow
Beginning cash position
1.25%151.02M
-10.37%138.76M
-9.18%139.39M
0.10%143.77M
1.25%151.02M
-1.94%149.16M
1.06%154.82M
0.08%153.47M
-4.98%143.62M
-1.94%149.16M
Current changes in cash
-1,109.49%-18.84M
-73.19%-6.57M
-146.67%-630K
-144.48%-4.38M
-31.12%-7.26M
163.25%1.87M
6.15%-3.79M
1,042.71%1.35M
348.27%9.85M
-475.83%-5.54M
End cash Position
-12.47%132.19M
-12.47%132.19M
-10.37%138.76M
-9.18%139.39M
0.10%143.77M
1.25%151.02M
1.25%151.02M
1.06%154.82M
0.08%153.47M
-4.98%143.62M
Free cash flow
-10.89%-30.81M
-13.83%-6.66M
32.31%-5.18M
-37.31%-11.66M
-26.30%-7.32M
-14.63%-27.79M
-44.63%-5.85M
-8.50%-7.65M
11.94%-8.49M
-65.50%-5.79M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -10.89%-30.81M-13.83%-6.66M32.31%-5.18M-37.31%-11.66M-26.30%-7.32M-14.63%-27.79M-44.63%-5.85M-8.50%-7.65M11.94%-8.49M-65.50%-5.79M
Net income from continuing operations 9.48%-43M-14.53%-11.62M-8.28%-12.21M19.54%-10.55M33.53%-8.62M0.99%-47.51M29.00%-10.15M8.79%-11.28M-25.57%-13.11M-19.20%-12.97M
Other non cash items ----------------------845K--0--0--------
Change In working capital 9.86%2.75M160.36%2.89M2,027.20%4.61M-1,809.64%-3.76M-153.63%-982K-53.27%2.51M-73.60%1.11M-118.03%-239K94.59%-197K-47.27%1.83M
-Change in receivables -46.28%260K-34.25%-729K-19.71%2.07M63.30%-236K6.87%-840K-91.86%484K-116.13%-543K2,931.29%2.57M41.38%-643K-123.96%-902K
-Change in prepaid assets 7.02%-278K-26.44%128K84.52%286K-80.12%-589K65.78%-103K-30,000.00%-299K61.99%174K5,766.77%155K-276.97%-327K-1,249.11%-301K
-Change in payables and accrued expense 54.03%2.85M141.11%3.57M176.03%2.26M-479.95%-2.94M-101.52%-39K416.27%1.85M102.65%1.48M-309.84%-2.97M131.45%773K1,049.48%2.56M
-Change in other working capital -115.86%-75K------------------473K--0--0--0--473K
Cash from discontinued investing activities
Operating cash flow -10.89%-30.81M-13.83%-6.66M32.31%-5.18M-37.31%-11.66M-26.30%-7.32M-14.63%-27.79M-44.63%-5.85M-8.50%-7.65M11.94%-8.49M-65.50%-5.79M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -59.61%11.98M-95.67%89K-49.46%4.55M-60.31%7.28M-77.13%59K39.29%29.65M83,341.56%2.06M30.28%9M54.90%18.33M-89.84%258K
Net common stock issuance -59.52%11.28M--0-51.89%4.11M--------32.83%27.88M41,554.98%1.19M29.65%8.53M--------
Proceeds from stock option exercised by employees -61.09%691K-89.75%89K-5.33%444K-45.30%99K-77.13%59K75.84%1.78M456,942.11%868K-8.62%469K46.65%181K-30.92%258K
Cash from discontinued financing activities
Financing cash flow -59.61%11.98M-95.67%89K-49.46%4.55M-60.31%7.28M-77.13%59K39.29%29.65M83,341.56%2.06M30.28%9M54.90%18.33M-89.84%258K
Net cash flow
Beginning cash position 1.25%151.02M-10.37%138.76M-9.18%139.39M0.10%143.77M1.25%151.02M-1.94%149.16M1.06%154.82M0.08%153.47M-4.98%143.62M-1.94%149.16M
Current changes in cash -1,109.49%-18.84M-73.19%-6.57M-146.67%-630K-144.48%-4.38M-31.12%-7.26M163.25%1.87M6.15%-3.79M1,042.71%1.35M348.27%9.85M-475.83%-5.54M
End cash Position -12.47%132.19M-12.47%132.19M-10.37%138.76M-9.18%139.39M0.10%143.77M1.25%151.02M1.25%151.02M1.06%154.82M0.08%153.47M-4.98%143.62M
Free cash flow -10.89%-30.81M-13.83%-6.66M32.31%-5.18M-37.31%-11.66M-26.30%-7.32M-14.63%-27.79M-44.63%-5.85M-8.50%-7.65M11.94%-8.49M-65.50%-5.79M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.